Clinical Quality Registries (CQRs) can improve the quality and safety of care by benchmarking clinical practice, informing policy and service design, feeding information back to providers, and complementing research about the effectiveness of care.1 Given their effectiveness for driving improvements in practice,2 ongoing CQRs have been established in many clinical domains internationally. National CQRs for dementia, however, are relatively new and currently limited to a cluster of Scandinavian countries.3 New dementia CQRs are being developed and implemented in several countries. For example, the Australian Dementia Registry (ADNet) ultimately aims to capture and monitor all persons with dementia or mild cognitive impairment at the point of diagnosis via memory or private specialist clinics.4 However, registries must cover a significant proportion of the population they intend to monitor. Limitations in coverage can stifle their benefits3 and efforts to maximise coverage are therefore important. Notably, dementia diagnosis often occurs outside of memory or private specialist clinics,5 so these settings have limited capacity to capture the entire eligible population of individuals with dementia.
|Number of pages||2|
|Journal||Australian and New Zealand Journal of Public Health|
|Early online date||31 Aug 2020|
|Publication status||Published - Dec 2020|
Bibliographical noteThis is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
- care assessment
- Clinical Quality Registries (CQRs)